San Francisco, CA12 Active Studies

Type 1 Diabetes Clinical Trials in San Francisco, CA

Find 12 actively recruiting type 1 diabetes clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

12
Active Trials
9
Sponsors
3,581
Enrolling

Recruiting Type 1 Diabetes Studies in San Francisco

NCT06654713Recruiting

Commercial or Open Source Closed Loop Impact on Pregnancy Study

The goal of this observational study is to better understand what happens when pregnant people with type 1 diabetes (T1D) use automated insulin delivery (AID) systems. The main questions this study ai...

San Francisco, CA1,000 participantsUniversity of California, San Francisco
View Study Details
NCT07088068Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insul...

San Francisco, CAPHASE3723 participantsSanofi
View Study Details
NCT07260110Recruiting

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

This study is an observational, longitudinal, non-interventional real-world study in the United States. The study is meant to describe the experience of participants with a history of stage 2 type 1 d...

San Francisco, CA550 participantsSanofi
View Study Details
NCT07228117Recruiting

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

The purpose of this study is to check that a new insulin pump, called NMX8, is safe when used with a continuous glucose monitoring sensor called Disposable Sensor 5/Simplera Sync in people with diabet...

San Francisco, CANA400 participantsMedtronic MiniMed, Inc.
View Study Details
NCT06481904Recruiting

Registry for Stage 2 Type 1 Diabetes

Stage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyper...

San Francisco, CA200 participantsSanofi
View Study Details
NCT07187531Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Typ...

San Francisco, CAPHASE2159 participantsSAb Biotherapeutics, Inc.
View Study Details
NCT06883344Recruiting

Automated Insulin for Management of Intrapartum Glycemia

The goal of this clinical trial is learn if automated insulin delivery (AID) systems can be used for glucose management during labor/delivery for pregnant people with type 1 diabetes (T1D). The main q...

San Francisco, CANA150 participantsUniversity of California, San Francisco
View Study Details
NCT07061574Recruiting

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in person...

San Francisco, CAPHASE1120 participantsCity of Hope Medical Center
View Study Details
NCT02734277Recruiting

Type 1 Diabetes Extension Study

This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodula...

San Francisco, CA111 participantsNational Institute of Allergy and Infectious Diseases (NIAID)
View Study Details
NCT07224321Recruiting

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 10 to \<18 year...

San Francisco, CAPHASE2100 participantsMannkind Corporation
View Study Details
NCT04786262Recruiting

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia....

San Francisco, CAPHASE352 participantsVertex Pharmaceuticals Incorporated
View Study Details
NCT06919354Recruiting

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell the...

San Francisco, CAPHASE116 participantsGentiBio, Inc
View Study Details

About Type 1 Diabetes Clinical Trials in San Francisco

Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells in the pancreas. It typically develops in childhood or young adulthood and requires lifelong insulin therapy. Research is exploring artificial pancreas systems, immunotherapy, and beta cell replacement.

There are currently 12 type 1 diabetes clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 3,581 participants. Research is being sponsored by University of California, San Francisco, Sanofi, Medtronic MiniMed, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Type 1 Diabetes Clinical Trials in San Francisco — FAQ

Are there type 1 diabetes clinical trials in San Francisco?

Yes, there are 12 type 1 diabetes clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What type 1 diabetes treatments are being tested?

The 12 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for type 1 diabetes.

Data updated July 21, 2026 from ClinicalTrials.gov